| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Pliant Therapeutics Inc (NASDAQ: PLRX)
PLRX Technical Analysis
5
| As on 9th Jun 2023 PLRX STOCK Price closed @ 22.58 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 13.84 & Strong Buy for SHORT-TERM with Stoploss of 11.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PLRXSTOCK Price
| Open | 22.70 | Change | Price | % |
| High | 23.09 | 1 Day | -0.19 | -0.83 |
| Low | 22.13 | 1 Week | 0.95 | 4.39 |
| Close | 22.58 | 1 Month | -5.42 | -19.36 |
| Volume | 562178 | 1 Year | 7.29 | 47.68 |
| 52 Week High 36.26 | 52 Week Low 4.11 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| PLRX Daily Charts |
PLRX Intraday Charts |
Whats New @ Bazaartrend |
PLRX Free Analysis |
|
|
PLRX Important Levels Intraday
| RESISTANCE | 24.43 |
| RESISTANCE | 23.84 |
| RESISTANCE | 23.47 |
| RESISTANCE | 23.10 |
| SUPPORT | 22.06 |
| SUPPORT | 21.69 |
| SUPPORT | 21.32 |
| SUPPORT | 20.73 |
PLRX Forecast April 2024
| 4th UP Forecast | 29.27 |
| 3rd UP Forecast | 27.12 |
| 2nd UP Forecast | 25.8 |
| 1st UP Forecast | 24.47 |
| 1st DOWN Forecast | 20.69 |
| 2nd DOWN Forecast | 19.36 |
| 3rd DOWN Forecast | 18.04 |
| 4th DOWN Forecast | 15.89 |
PLRX Weekly Forecast
| 4th UP Forecast | 26.61 |
| 3rd UP Forecast | 25.32 |
| 2nd UP Forecast | 24.52 |
| 1st UP Forecast | 23.72 |
| 1st DOWN Forecast | 21.44 |
| 2nd DOWN Forecast | 20.64 |
| 3rd DOWN Forecast | 19.84 |
| 4th DOWN Forecast | 18.55 |
PLRX Forecast2024
| 4th UP Forecast | 85.55 |
| 3rd UP Forecast | 65.36 |
| 2nd UP Forecast | 52.87 |
| 1st UP Forecast | 40.39 |
| 1st DOWN Forecast | 4.77 |
| 2nd DOWN Forecast | -7.71 |
| 3rd DOWN Forecast | -20.2 |
| 4th DOWN Forecast | -40.39 |
Pliant Therapeutics Inc ( NASDAQ USA Symbol : PLRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PLRX Business Profile
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in Phase II single ascending dose/multiple ascending dose trails and completed Phase Ib proof-of-mechanism trials for the treatment of idiopathic pulmonary fibrosis and primary sclerosing cholangitis. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which completed Phase 1 clinical trial for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis. In addition, it is developing two additional preclinical integrin-based programs, which include an oncology program, as well as a program for an allosteric agonistic monoclonal antibody against an undisclosed integrin receptor for treatment of muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was founded in 2015 and is based in South San Francisco, California. Address: 260 Littlefield Avenue, South San Francisco, CA, United States, 94080
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service